Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Mol Neurobiol. 2019 Jun 15;56(12):8203–8219. doi: 10.1007/s12035-019-01668-9

Fig. 2. Effects of recombinant fibroblast growth factor-2 (rFGF-2) on short-term neurobehavioral function and brain edema.

Fig. 2

a 9 μg rFGF-2 improved modified Garcia’s score and beam balance score at 24 h after subarachnoid hemorrhage (SAH). Data are expressed as median ± 25th-75th percentiles (n = 6-10 per group). † P < 0.01 vs. Sham+PBS, ‡ P < 0.05 and § P < 0.01 vs. SAH+phosphate buffered saline (PBS). b rFGF-2 treatment improved brain water content at 24 h after SAH. Data are expressed as mean + standard deviation (n = 6 per group). * P < 0.05 and † P < 0.01 vs. Sham+PBS, ‡ P < 0.05 and § P < 0.01 vs. SAH+PBS.